These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26384273)

  • 1. Breast Cancer Stem Cell Correlates as Predicative Factors for Radiation Therapy.
    Wolfe AR; Woodward WA
    Semin Radiat Oncol; 2015 Oct; 25(4):251-9. PubMed ID: 26384273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.
    Gudadze M; Kankava Q; Mariamidze A; Burkadze G
    Georgian Med News; 2014 Mar; (228):81-7. PubMed ID: 24743129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced extinction of CD24 stem-like breast cancer marker alone promotes radiation resistance through the control of oxidative stress.
    Bensimon J; Biard D; Paget V; Goislard M; Morel-Altmeyer S; Konge J; Chevillard S; Lebeau J
    Mol Carcinog; 2016 Mar; 55(3):245-54. PubMed ID: 25641732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRP78 mediates radiation resistance of a stem cell-like subpopulation within the MCF-7 breast cancer cell line.
    Li B; Cheng XL; Yang YP; Li ZQ
    Oncol Rep; 2013 Nov; 30(5):2119-26. PubMed ID: 24002052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cells in breast cancer and metastasis.
    Lawson JC; Blatch GL; Edkins AL
    Breast Cancer Res Treat; 2009 Nov; 118(2):241-54. PubMed ID: 19731012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation treatment generates therapy-resistant cancer stem cells from less aggressive breast cancer cells.
    Printz C
    Cancer; 2012 Jul; 118(13):3225. PubMed ID: 22711575
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular biology of breast cancer stem cells: potential clinical applications.
    Nguyen NP; Almeida FS; Chi A; Nguyen LM; Cohen D; Karlsson U; Vinh-Hung V
    Cancer Treat Rev; 2010 Oct; 36(6):485-91. PubMed ID: 20231058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation resistance of breast cancer stem cells: understanding the clinical framework.
    Debeb BG; Xu W; Woodward WA
    J Mammary Gland Biol Neoplasia; 2009 Mar; 14(1):11-7. PubMed ID: 19252973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiation-induced G2 phase arrest may contribute to the radioresistance of breast cancer stem cells].
    Tian YH; Xie GZ; Ren C; Sun QQ; Sun AM; Liu Y; Yuan YW
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):53-6. PubMed ID: 21269956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The paradigm of personalized therapy in oncology.
    Gasparini G; Longo R
    Expert Opin Ther Targets; 2012 Mar; 16 Suppl 1():S7-16. PubMed ID: 22073968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.
    Wei W; Tweardy DJ; Zhang M; Zhang X; Landua J; Petrovic I; Bu W; Roarty K; Hilsenbeck SG; Rosen JM; Lewis MT
    Stem Cells; 2014 Oct; 32(10):2571-82. PubMed ID: 24891218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer stem cells: an update.
    Iqbal J; Chong PY; Tan PH
    J Clin Pathol; 2013 Jun; 66(6):485-90. PubMed ID: 23322821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
    Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of cancer stem cells in ductal invasive carcinoma of breast (review).
    Gudadze M; Kankava K; Mariamidze A; Burkadze G
    Georgian Med News; 2013 Sep; (222):44-50. PubMed ID: 24099814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.
    Mallini P; Lennard T; Kirby J; Meeson A
    Cancer Treat Rev; 2014 Apr; 40(3):341-8. PubMed ID: 24090504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of stem cell deregulation and breast cancer: an emerging hypothesis.
    Kumar DH; Kutty MK
    Indian J Pathol Microbiol; 2012; 55(2):147-53. PubMed ID: 22771633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome.
    Hashimoto K; Shimizu C; Tsuda H; Saji S; Osaki A; Shigekawa T; Aogi K
    Oncology; 2012; 82(3):168-74. PubMed ID: 22433454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer stem cells: obstacles to therapy.
    Smalley M; Piggott L; Clarkson R
    Cancer Lett; 2013 Sep; 338(1):57-62. PubMed ID: 22554712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current challenges and future perspectives of radiotherapy for locally advanced breast cancer.
    Ghiam AF; Spayne J; Lee J
    Curr Opin Support Palliat Care; 2014 Mar; 8(1):46-52. PubMed ID: 24441684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor initiating cancer stem cells from human breast cancer cell lines.
    Han JS; Crowe DL
    Int J Oncol; 2009 May; 34(5):1449-53. PubMed ID: 19360358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.